Literature DB >> 24413772

Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.

Yan Zhang1, Yu Liu, Xue-Hai Zhu, Xiao-Dong Zhang, Ding-Sheng Jiang, Zhou-Yan Bian, Xiao-Fei Zhang, Ke Chen, Xiang Wei, Lu Gao, Li-Hua Zhu, Qinglin Yang, Guo-Chang Fan, Wayne B Lau, Xinliang Ma, Hongliang Li.   

Abstract

AIMS: Dickkopf-3 (DKK3), a secreted protein in the Dickkopf family, is expressed in various tissues, including the heart, and has been shown to play an important role in tissue development. However, the biological function of DKK3 in the heart remains largely unexplored. This study aimed to examine the role of DKK3 in pathological cardiac hypertrophy. METHODS AND
RESULTS: We performed gain-of-function and loss-of-function studies using DKK3 cardiac-specific transgenic (TG) mice and DKK3 knockout (KO) mice (C57BL/6J background). Cardiac hypertrophy was induced by aortic banding. Cardiac hypertrophy was evaluated by echocardiographic, haemodynamic, pathological, and molecular analyses. Our results demonstrated that the loss of DKK3 exaggerated pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction, whereas the overexpression of DKK3 protected the heart against pressure overload-induced cardiac remodelling. These beneficial effects were associated with the inhibition of the ASK1-JNK/p38 (apoptosis signal-regulating kinase 1-c-Jun N-terminal kinase/p38) signalling cascade. Parallel in vitro experiments confirmed these in vivo observations. Co-immunoprecipitation experiments suggested that physical interactions occurred between DKK3 and ASK1. Moreover, rescue experiments indicated that, in DKK3 TG mice, the activation of ASK1 using a cardiac-specific conditional ASK1 transgene reduced the functionality of DKK3 in response to pressure overload; furthermore, the inactivation of ASK1 by dominant-negative ASK1 rescued pressure overload-induced cardiac abnormalities in DKK3 KO mice.
CONCLUSION: Taken together, our findings indicate that DKK3 acts as a cardioprotective regulator of pathological cardiac hypertrophy and that this function largely occurs via the regulation of ASK1-JNK/p38 signalling.

Entities:  

Keywords:  ASK1; Cardiac hypertrophy; DKK3; Fibrosis

Mesh:

Substances:

Year:  2014        PMID: 24413772      PMCID: PMC6279202          DOI: 10.1093/cvr/cvu004

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  41 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

2.  Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.

Authors:  He Huang; Qi-Zhu Tang; Ai-Bing Wang; Manyin Chen; Ling Yan; Chen Liu; Hong Jiang; Qinglin Yang; Zhou-Yan Bian; Xue Bai; Li-Hua Zhu; Lang Wang; Hongliang Li
Journal:  Hypertension       Date:  2010-06-28       Impact factor: 10.190

3.  Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.

Authors:  Maria Papatriantafyllou; Gerhard Moldenhauer; Julia Ludwig; Anna Tafuri; Natalio Garbi; Gorana Hollmann; Günter Küblbeck; Alexandra Klevenz; Sabine Schmitt; Georg Pougialis; Christof Niehrs; Hermann-Josef Gröne; Gunter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

4.  Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.

Authors:  Kazuhiko Ochiai; Masami Watanabe; Hideo Ueki; Peng Huang; Yasuyuki Fujii; Yasutomo Nasu; Hirofumi Noguchi; Takeshi Hirata; Masakiyo Sakaguchi; Nam-Ho Huh; Yuji Kashiwakura; Haruki Kaku; Hiromi Kumon
Journal:  Biochem Biophys Res Commun       Date:  2011-08-03       Impact factor: 3.575

5.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.

Authors:  Jersey Chen; Sharon-Lise T Normand; Yun Wang; Harlan M Krumholz
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

6.  Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.

Authors:  Fernando Abarzua; Masakiyo Sakaguchi; Mikiro Takaishi; Yasutomo Nasu; Kyouhei Kurose; Shin Ebara; Masahiro Miyazaki; Masayoshi Namba; Hiromi Kumon; Nam-ho Huh
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Dickkopf-3/REIC functions as a suppressor gene of tumor growth.

Authors:  Sen-Yung Hsieh; Pei-Shan Hsieh; Cheng-Tang Chiu; Wai-Ying Chen
Journal:  Oncogene       Date:  2004-12-09       Impact factor: 9.867

8.  REIC/Dkk-3 induces cell death in human malignant glioma.

Authors:  Yoshifumi Mizobuchi; Kazuhito Matsuzaki; Kazuyuki Kuwayama; Keiko Kitazato; Hideo Mure; Teruyoshi Kageji; Shinji Nagahiro
Journal:  Neuro Oncol       Date:  2008-04-28       Impact factor: 12.300

9.  Closely related bird species demonstrate flexibility between beak morphology and underlying developmental programs.

Authors:  Ricardo Mallarino; Otger Campàs; Joerg A Fritz; Kevin J Burns; Olivia G Weeks; Michael P Brenner; Arhat Abzhanov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

10.  Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin.

Authors:  Eun-Ju Lee; Minwha Jo; Seung Bae Rho; Kyoungsook Park; Yae-Na Yoo; Junsoo Park; Myounghee Chae; Wei Zhang; Je-Ho Lee
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

View more
  25 in total

1.  Decreased WNT/β-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene.

Authors:  Caroline Le Dour; Coline Macquart; Fusako Sera; Shunichi Homma; Gisele Bonne; John P Morrow; Howard J Worman; Antoine Muchir
Journal:  Hum Mol Genet       Date:  2017-01-15       Impact factor: 6.150

Review 2.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 3.  The Stress-Response MAP Kinase Signaling in Cardiac Arrhythmias.

Authors:  Xun Ai; Jiajie Yan; Elena Carrillo; Wenmao Ding
Journal:  Rev Physiol Biochem Pharmacol       Date:  2016       Impact factor: 5.545

4.  The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.

Authors:  Peng Zhang; Pi-Xiao Wang; Ling-Ping Zhao; Xin Zhang; Yan-Xiao Ji; Xiao-Jing Zhang; Chun Fang; Yue-Xin Lu; Xia Yang; Mao-Mao Gao; Yan Zhang; Song Tian; Xue-Yong Zhu; Jun Gong; Xin-Liang Ma; Feng Li; Zhihua Wang; Zan Huang; Zhi-Gang She; Hongliang Li
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

Review 5.  The role of Wnt regulation in heart development, cardiac repair and disease: A tissue engineering perspective.

Authors:  Aric Pahnke; Genna Conant; Locke Davenport Huyer; Yimu Zhao; Nicole Feric; Milica Radisic
Journal:  Biochem Biophys Res Commun       Date:  2015-11-26       Impact factor: 3.575

Review 6.  Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD.

Authors:  Julian C Bachmann; Simon J Baumgart; Anna K Uryga; Markus H Bosteen; Giulia Borghetti; Michael Nyberg; Kate M Herum
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

7.  Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway.

Authors:  Dan Lu; Dan Bao; Wei Dong; Ning Liu; Xu Zhang; Shan Gao; Wenping Ge; Xiang Gao; Lianfeng Zhang
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

Review 8.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

9.  Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1.

Authors:  Lang Jiang; Lingyun Ren; Xin Guo; Jing Zhao; Hao Zhang; Shanshan Chen; Sheng Le; Hao Liu; Ping Ye; Manhua Chen; Jiahong Xia
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

10.  Dickkopf-3 (DKK3) Signaling in IL-1α-Challenged Chondrocytes: Involvement of the NF-κB Pathway.

Authors:  Javier Conde; Clara Ruiz-Fernandez; Vera Francisco; Morena Scotece; Rodolfo Gómez; Francisca Lago; Miguel Angel Gonzalez-Gay; Jesús Pino; Ali Mobasheri; Oreste Gualillo
Journal:  Cartilage       Date:  2020-06-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.